Burns: Clinical Trials

10 trials for Burns, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 terminated. 10 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Terminated 10
Phase 28Terminated 8

Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fenofibrate and Propranolol in Burn Patients
Fenofibrate, Placebo, Propranolol - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston182015-11-012019-11-29
Propranolol in Severely Burned Children
Propranolol, Placebo - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston632013-12-012019-09-24
Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
unfractionated heparin, placebo - Inhalation Injury, Burn Injury
Phase 3TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)132013-10-012022-02-16
Protective Effects of Propranolol in Adults
Propranolol, Placebo - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston472013-07-012019-11-29
Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin
Metformin, Sugar pill - Insulin Resistance, Hypermetabolism
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston362012-11-012019-11-29
Epidermal Cells Delivery and Acute Burns
autologous epidermal cells harvesting kits, classic skin grafts - Burn
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris512008-12-012012-07-26
Evaluation Perioperative Nutrition on Donor Site Healing in Patients Undergoing Reconstructive Burn Surg
Juven (Ross Products) protein supplement - Burn, Reconstructive Surgical Procedure
Phase 2 / Phase 3TerminatedShriners Hospitals for Children382005-06-012012-06-19
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston11262004-01-012019-11-29
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
Sulfamylon 5% and Silver Nitrate Soaks - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston981995-07-012023-06-22
Bone Disease in Severely Burned Children
Tetracycline, Duel Energy X-Ray Absorptiometry (DEXA), Bone Biopsy - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston2541992-10-012014-06-06

Narrower conditions

Hyperglycemia (1)  ·  Insulin Resistance (1)  ·  Motor Activity (1)  ·  Wound Infection (1)  ·  Wounds and Injuries (1)

Broader conditions

Wounds and Injuries (9)  ·  Behavior (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Infections (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Metoprolol (4)  ·  Propranolol (4)  ·  Absorptiometry, Photon (1)  ·  Exercise (1)  ·  Exercise Therapy (1)  ·  Fenofibrate (1)  ·  Fluconazole (1)  ·  Growth Hormone (1)  ·  Heparin (1)  ·  High-Energy Shock Waves (1)  ·  Human Growth Hormone (1)  ·  Itraconazole (1)  ·  Ketoconazole (1)  ·  Mafenide (1)  ·  Magnetic Resonance Spectroscopy (1)

Sponsors

The University of Texas Medical Branch, Galveston (7)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Shriners Hospitals for Children (1)

Countries

United States (8)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Netherlands (1)

Top investigators

David N Herndon, MD (6)  ·  Klein Gordon, M.D. (1)  ·  Marcus J Schultz, MD-PhD (1)  ·  Theresa M Mayes, RD,LD (1)

Results publications

PMID 19734776, PMID 20881067, PMID 22463890, PMID 22606232, PMID 22895351, PMID 23150682, PMID 23303450, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24661817, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 27171844, PMID 27433905, PMID 28240622

NIH funding

P50GM060338 (1)